Migraine episodes are tough, but the women who fight through them are tougher. That’s the message from Allergan in its evolved Botox for chronic migraine marketing. New TV ads, first begun in the fall ...
CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...
For the second time in less than a year, the Food and Drug Administration has warned Irvine-based Allergan Inc. that advertisements for its anti-wrinkle drug Botox are misleading and should be pulled.
Allergan has been more than willing to do whatever necessary to protect its secret process for making blockbuster Botox. After filing a trade theft investigation against a competitor, the drugmaker ...
Concerns about eventual competition for Allergan Inc.’s cash cow Botox don’t seem to be weighing on the Irvine drug maker’s shares. For now, investors seem content with the company’s strong ...
Kimberly Horowitz is an international gem buyer specializing in diamonds, brokering deals in the hundreds of thousands of dollars. In her line of work, a confident, relaxed appearance can be the ...
Irvine-based Allergan Inc., maker of wrinkle-fighting Botox and other drugs, is gaining more attention on Wall Street. At least one analyst even crafted a pun—intended or otherwise—to lay out a case ...
IRVINE, Calif., Nov. 16, 2020 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX® Cosmetic Day on Wednesday, November 18, 2020. The event is ...
The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...
(Reuters) - Allergan Plc on Tuesday forecast 2019 revenue below expectations on looming competition for some of its top drugs, and shelved plans to sell its women's health business. The Botox maker's ...
NEW YORK (Reuters) - Regulators seem inclined to approve Allergan Inc's wrinkle drug Botox to prevent migraine headaches in millions of Americans, industry analysts said, based on information the ...
The company that makes Botox is the subject of the latest biopharma mega-deal. Chicago-based AbbVie said Tuesday it would acquire Ireland-headquartered Allergan for $63 billion, or $78.45 per share, ...